LAS41005

DRUG2 trials

Sponsors

Almirall, S.A.

Conditions

Actinic Keratosis

Phase 2

LAS41005 in Hyperkeratotic Actinic Keratosis

CompletedNCT01358851

Almirall, S.A.Actinic Keratosis

Start: 2011-04-30End: 2012-08-31Updated: 2015-05-29

Phase 3

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

CompletedNCT00987246

Almirall, S.A.Actinic Keratosis

Start: 2008-06-30End: 2009-06-30Updated: 2015-07-28

Related Papers

A prospective randomized exploratory study comparing the efficacy of once‐daily topical 0.5% 5‐fluorouracil in combination with 10.0% salicylic acid (5‐<scp>FU</scp>/<scp>SA</scp>) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis

Journal of the European Academy of Dermatology and Venereology2014-09-2550 citations